Notably, ZMYND8 is overexpressed in breast cancer, where it promotes metastasis through dysregulation of HIF signaling, the cGAS-STING pathway, and cholesterol metabolism [21,29,30]. Here, ZMYND8 is linked to breast carcinoma.